Showing results (61-70 of 69) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 69 results.
Autoimmunity Reviews|September 4, 2014
Profound symptomatic hypogammaglobulinemia: a rare late complication after rituximab treatment for immune thrombocytopenia. Report of 3 cases and systematic review of the literatureRomain Levy, Matthieu Mahévas, Lionel Galicier, et al.
Transfusion Medicine Reviews|July 23, 2019
Transfusion-Transmitted Hepatitis E Virus Infection in FrancePierre Gallian, Elodie Pouchol, Rachid Djoudi, et al.
Transplantation|February 1, 2002
Long-term kidney graft survival across a positive historic but negative current sensitized cross-matchChristophe Baron, Myriam Pastural, Philippe Lang, et al.
Blood|May 9, 2008
Rituximab efficacy and safety in adult splenectomy candidates with chronic immune thrombocytopenic purpura: results of a prospective multicenter phase 2 studyBertrand Godeau, Raphael Porcher, Olivier Fain, et al.
The Journal of Clinical Investigation|December 18, 2012
B cell depletion in immune thrombocytopenia reveals splenic long-lived plasma cellsMatthieu Mahévas, Pauline Patin, François Huetz, et al.
Blood|May 9, 2012
Outcomes 5 years after response to rituximab therapy in children and adults with immune thrombocytopeniaVivek L Patel, Matthieu Mahévas, Soo Y Lee, et al.
Haematologica|March 1, 2013
A retrospective pilot evaluation of switching thrombopoietic receptor-agonists in immune thrombocytopeniaMehdi Khellaf, Jean-François Viallard, Mohamed Hamidou, et al.
Blood|August 12, 2011
Romiplostim safety and efficacy for immune thrombocytopenia in clinical practice: 2-year results of 72 adults in a romiplostim compassionate-use programMehdi Khellaf, Marc Michel, Philippe Quittet, et al.
Blood|October 9, 2014
Safety and efficacy of rituximab in adult immune thrombocytopenia: results from a prospective registry including 248 patientsMehdi Khellaf, Anaïs Charles-Nelson, Olivier Fain, et al.
Pageof 7